Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
The EMBO Journal|February 27, 2026
Molecular evolution of animal agingDaniel H Nussey, Fabrizio d'Adda di Fagagna, Allison J Bardin, et al.
Nature|July 13, 2019
Author Correction: L1 drives IFN in senescent cells and promotes age-associated inflammationMarco De Cecco, Takahiro Ito, Anna P Petrashen, et al.
Science Translational Medicine|March 4, 2016
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in gliomaCarl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, et al.
Cell|April 20, 2019
SIRT6 Is Responsible for More Efficient DNA Double-Strand Break Repair in Long-Lived SpeciesXiao Tian, Denis Firsanov, Zhihui Zhang, et al.
Lancet (London, England)|June 17, 2014
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trialEdward B Garon, Tudor-Eliade Ciuleanu, Oscar Arrieta, et al.
Aging|May 11, 2016
Sensitivity of primary fibroblasts in culture to atmospheric oxygen does not correlate with species lifespanAlison Patrick, Michael Seluanov, Chaewon Hwang, et al.
Mechanisms of Ageing and Development|September 19, 2020
The conundrum of human immune system "senescence"Graham Pawelec, Anne Bronikowski, Stephen C Cunnane, et al.
The Lancet. Oncology|August 19, 2014
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete responseEvandro de Azambuja, Andrew P Holmes, Martine Piccart-Gebhart, et al.
The Lancet. Oncology|January 16, 2015
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsJames Chih-Hsin Yang, Yi-Long Wu, Martin Schuler, et al.
Nature Aging|April 28, 2023
Rare genetic coding variants associated with human longevity and protection against age-related diseasesJhih-Rong Lin, Patrick Sin-Chan, Valerio Napolioni, et al.
Pageof 22